2.
Elsevier ClinicalKey Drug Monograph
Content last updated: April 1, 2024.
Adverse Reactions
Acute and prolonged hypotensive episodes, sinus tachycardia, cardiac arrhythmias, and/or angina have all occurred with parenteral administration of phentolamine. These effects may be due to the drug's cardiac-stimulating and vasodilatory effects. Other adverse effects seen with phentolamine therapy include weakness, dizziness, flushing, and orthostatic hypotension. Flushing may be due to dilation of the facial blood vessels. During reversal of soft tissue anesthesia in studies of pediatric and adult patients (n = 418), phentolamine (OraVerse) was associated with tachycardia, bradycardia, and elevations in blood pressure (hypertension) in 5%, 2%, and < 3% of patients, respectively.
Adverse Reactions
Nausea and vomiting can occur with the parenteral use of phentolamine. Diarrhea secondary to phentolamine may result from stimulation of GI smooth muscle. During reversal of soft tissue anesthesia in studies of pediatric and adult patients (n = 418), phentolamine (OraVerse) was associated with diarrhea, vomiting, and upper abdominal pain in less than 3% of patients. Dysgeusia was reported in 6% of patients treated with phentolamine ophthalmic solution in clinical trials.
Adverse Reactions
1. conjunctival hyperemia
2. dental pain
3. ocular pain
4. abdominal pain
5. bradycardia
6. diarrhea
7. dysgeusia
8. headache
9. hypertension
10. injection site reaction
11. paresthesias
12. pruritus
13. sinus tachycardia
14. vomiting
15. angina
16. dizziness
17. ejaculation dysfunction
18. flushing
19. nasal congestion
20. nausea
21. orthostatic hypotension
22. priapism
23. weakness
Adverse Reactions
Priapism has occasionally been reported after intracavernosal injection of phentolamine into the penis. Penile ecchymosis is a common adverse effect of this treatment, as is transient pain. Ejaculation dysfunction has also been reported.
Adverse Reactions
The most common ocular adverse reactions reported in patients receiving phentolamine ophthalmic solution in clinical trials were ocular pain, stinging, and burning (16%) and conjunctival hyperemia (12%).
Adverse Reactions
Cerebrovascular spasm and cerebrovascular occlusion have been reported following phentolamine administration. During reversal of soft tissue anesthesia in studies of pediatric and adult patients (n = 418), phentolamine (OraVerse) was associated with headache in 3% of patients. The incidence of headache increased with increasing dosage. Paresthesias occurred in < 3% of patients. Paraesthesias were transient and resolved within 48 hours.